جستجوی استاد راهنمای دانشگاهی

• Neuropharmacology
• Analytical Chemistry
• Liquid Chromatography
• +۷ مورد دیگر

Ann Van Eeckhaut is a Professor in the Department of Pharmaceutical and Pharmacological Sciences at the Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel. With an h-index of 25 and over 2681 citations, she leads significant research in neuropharmacological analysis methods, specializing in the development of miniaturized liquid chromatography techniques for neurotransmitter and drug analysis in biological samples. Her research expertise spans: Neurochemical and neuropharmacological analysis requiring sensitive methods for low-concentration compounds Development of miniaturized LC methods coupled to fluorescence, electrochemical, and MS/MS detection Quantification of neuropeptides in microdialysis samples using Nano LC-MS/MS Metabolite profiling for biomarker discovery in drug-resistant epilepsy Enantioselective analysis of neuro- and gliotransmitters Recent publications demonstrate her leadership in advancing analytical techniques for brain metabolomics, with increasing focus on 3D printing for sample preparation devices and natural compounds for neurodegenerative disease treatment. Her work bridges analytical chemistry, neuroscience, and translational pharmacology, with particular emphasis on Parkinson's and Alzheimer's disease therapies. Scientific recognition includes: Project grant from Wetenschappelijk Fonds Willy Gepts (WFWG) in December 2021 for epilepsy biomarker research Dr. Van Eeckhaut actively supervises graduate research with 31 theses completed under her guidance. She leads multiple significant research projects including FWOSB173 (2024-2028) on ADHD medication during pregnancy, FWOAL1076 (2023-2026) on brain metabolomics, and VLIR418 (2022-2027) on levodopa-rich biomass for neurodegenerative diseases. Her research group maintains extensive collaboration networks across neuroscience and analytical chemistry disciplines. Her laboratory specializes in developing cutting-edge analytical methods for neurochemical analysis, with particular focus on volume-limited samples and high-throughput requirements for modern pharmacological research.

• Biomedical Engineering
• Materials Science
• Design and synthesis of organic functional materials
• +۳ مورد دیگر

Dr. FANG Xiaofeng is a Research Professor in the Department of Biomedical Engineering at Southern University of Science and Technology (SUSTech). He leads a research group focused on developing advanced materials and imaging techniques for biomedical applications. His career includes postdoctoral training at SUSTech (2017-2019) following doctoral studies at Jilin University. Education: Ph.D. in Physical Electronics, Jilin University (2014-2017) M.S. in Organic Chemistry, Jilin University (2012-2014) B.S. in Chemistry, Jilin University (2008-2012) Research Focus: Dr. Fang's work spans three interconnected domains: 1) Design and synthesis of organic functional materials with tailored optical properties; 2) Super-resolution imaging techniques for biological systems; and 3) Integrated biosensing and phototherapy platforms. His research bridges materials chemistry, optical engineering, and translational medicine. Publication Trends: His recent articles (2021-2025) demonstrate a strong emphasis on polymer-based nanoplatforms for advanced bioimaging and therapy. Key innovations include NIR-II probes for deep-tissue imaging, photoswitchable materials for super-resolution microscopy, and targeted nanoconjugates for cancer theranostics. The work consistently integrates materials innovation with biomedical problem-solving. He currently leads a research group developing molecular probes and bio-optical imaging technologies. The laboratory focuses on four key areas: molecular probe design, bioanalysis and biosensors, optoelectronic functional materials, and biomedical applications. The team actively recruits postdoctoral researchers for cross-disciplinary projects.

• Bioanalysis
• Chromatography
• Mass Spectrometry
• +۵ مورد دیگر

Rolf Sparidans is an Assistant Professor in the Department of Pharmacology within the Faculty of Science at Utrecht University. His academic career spans over three decades, with expertise in bioanalytical chemistry and pharmaceutical sciences. He completed his education in Analytical Chemistry at Eindhoven Technical University in 1990, earned his PhD at Leiden University Medical Center in 1997, and conducted post-doctoral research at Utrecht University from 1997-2001. His research interests focus on developing and applying liquid chromatography-mass spectrometry methods for analyzing endogenous compounds and drugs, particularly in kidney pharmacology. His work centers on cystine, protein-bound uremic toxins (PBUTs), and short-chain fatty acids (SCFAs). His extensive publication record demonstrates consistent contributions to bioanalytical method development, particularly for kinase inhibitors and compounds relevant to kidney function. His recent publications (2022-2025) show a continued focus on pharmacokinetic studies of various kinase inhibitors, with particular attention to drug transporters (ABCB1, ABCG2), metabolism pathways, and analytical method development. His work bridges analytical chemistry with clinical pharmacology, particularly in understanding drug distribution across biological barriers. Sparidans teaches analytical courses, pharmacokinetics, and biotransformation within the Pharmaceutical Sciences program. He serves on the editorial board of the Journal of Chromatography B, demonstrating his standing in the analytical chemistry community.

Ebru Türköz Acarمشاهده پروفایل

دانشیار

• Analytical Chemistry
• Pharmaceutical Chemistry
• Bioanalysis
• +۵ مورد دیگر

Assoc. Prof. Dr. Ebru Türköz Acar is an academic staff member at the Faculty of Pharmacy of Yeditepe University , specializing in Analytical Chemistry . She holds a PhD in Chemistry from Ondokuz Mayıs University and has focused her career on method development for pharmaceutical and food safety analysis. Education: PhD in Chemistry (2009), MSc in Chemistry (2003), BSc in Chemistry Education (1999) Research interests: Electrochemical methods, HPLC-DAD techniques, antioxidant compounds, and pharmaceutical/nutritional analysis Her work spans pharmaceutical analysis (e.g., quantifying flurbiprofen, thiocolchicoside, and eplerenone formulations) and food safety (e.g., furfural derivatives in honey, phenolic profiling in fruit wines). She has led projects on nanoemulsions for drug delivery and validated analytical methods for toxic compounds like atropine. Recent publications highlight her expertise in method validation for pharmaceuticals and food matrices, with applications in oxidative stress biomarkers (3-nitrotyrosine) and drug formulation (solid lipid nanoparticles). She actively participates in academic duties including course instruction and administrative roles like Vice Dean and Quality Committee member.

Olivier Barbierمشاهده پروفایل

استاد

• Glucuronidation
• Bile acids metabolism
• Liver diseases
• +۷ مورد دیگر

Olivier Barbier is a Full Professor and currently serves as Vice-Dean for Research and Graduate Studies at the Faculty of Pharmacy, Université Laval. His academic career spans over 15 years with significant contributions in pharmacology, particularly in the field of glucuronidation and its role in liver diseases, cardiovascular disorders, and prostate cancer. As Vice-Dean, he oversees research initiatives and graduate programs at one of Canada's leading pharmacy faculties. Dr. Barbier's educational journey began with a Bachelor's degree in cell biology and physiology from François-Rabelais University in Tours, France, followed by a Master's degree in environmental sciences from Bordeaux I University. He completed his DEA in toxic interactions from University of Paris VII, earned his Doctorate in Physiology-Endocrinology from Laval University, and conducted post-doctoral research in lipidology and atherosclerosis at INSERM Unit in Lille, France. His research focuses on three primary areas: glucuronidation and liver diseases, cardiovascular diseases, and prostate cancer. Dr. Barbier's laboratory investigates how UDP-glucuronosyltransferase (UGT) enzymes metabolize bile acids, bilirubin, and androgens, with the goal of identifying novel therapeutic approaches. His work has demonstrated that fibrates and LXR activators stimulate bile acid glucuronidation in human liver cells, potentially offering new treatments for cholestatic liver diseases. He has also explored how omega-3 fatty acids and their derivatives like Protectin DX can enhance therapeutic responses to existing medications. Analysis of Dr. Barbier's recent publications reveals a strong emphasis on bile acid metabolism, particularly the role of glucuronidation in detoxification processes. His research increasingly incorporates nutraceutical approaches, combining omega-3 fatty acids with conventional therapeutics to improve treatment outcomes for liver diseases. There's also a growing focus on environmental toxicology, examining how metal exposure affects kidney function, particularly in pediatric populations. Dr. Barbier has successfully secured funding from major sources including the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada, Pharmaceutical Research and Manufacturers of Canada (Rx&D), and Pfizer Canada. His laboratory supports numerous graduate students and research professionals, contributing significantly to the training of the next generation of pharmacologists and toxicologists. As head of the Molecular Pharmacology Laboratory and co-director of the Bioanalytical Services with Dr. Chantal Guillemette, Dr. Barbier oversees sophisticated analytical capabilities including HPLC, GC/MS, and LC/MS/MS systems. His laboratory provides specialized services for hormone quantification and drug metabolism studies, supporting both academic and pharmaceutical research. The lab's expertise in measuring steroid hormones and their metabolites at picogram levels represents a significant technical achievement in the field of bioanalysis.

Matthew Ryen Lockettمشاهده پروفایل

دانشیار

• 3D Cell Culture
• Bioanalysis
• Chemically Modified Electrodes
• +۷ مورد دیگر

Matthew Ryen Lockett is an Associate Professor in the Department of Chemistry at the University of North Carolina at Chapel Hill, with strong affiliations to the UNC School of Medicine. His research focuses on developing innovative 3D cell culture platforms and measurement tools that better mimic in vivo tissue environments, with particular emphasis on oxygen's role in tissue homeostasis and cancer progression. Dr. Lockett received his BS in Chemistry from the University of Pittsburgh in 2005, followed by a PhD in Chemistry from the University of Wisconsin-Madison in 2009 working with Lloyd M. Smith. He completed his postdoctoral training at Harvard University with George M. Whitesides from 2010-2013. His research program addresses two major areas: tissue engineering and surface chemistry. In tissue engineering, his lab develops paper-based 3D culture systems that maintain physiologically relevant microenvironments for studying cancer biology, drug metabolism, and cellular responses to oxygen gradients. For surface chemistry, his group creates novel methods for modifying carbon and silicon electrodes to improve stability and functionality for applications in electrocatalysis and sensing. His interdisciplinary approach integrates concepts from chemistry, biomedical engineering, cellular and molecular biology, materials science, and toxicology to solve complex biological problems. Dr. Lockett's recent publications reveal a strong trend toward increasingly sophisticated 3D tissue models with precise oxygen control, alongside continued innovation in surface modification techniques for electrochemical applications. His work bridges fundamental chemical principles with translational biomedical applications, particularly in cancer research and drug development. Dr. Lockett has received numerous prestigious awards recognizing his contributions to analytical chemistry and biomedical research: Fellow, Royal Society of Chemistry (2024) The Analytical Scientist Power List, Mentors and Educators category (2023) Center for Environmental Health and Susceptibility Rising Star Award (2019) Top 40 under 40 Power List, The Analytical Scientist (2018) BioAnalysis Zone New Investigator Award (2017) Eli Lilly Young Investigator Award in Analytical Chemistry (2016) Dr. Lockett actively mentors graduate students and postdoctoral researchers in his lab, with several recent PhD graduates and undergraduate researchers. His lab operates with strong core values emphasizing creativity, inclusivity, and teamwork, maintaining a zero-tolerance policy against all forms of oppression. The lab has secured significant funding to support its research on tissue engineering and surface chemistry, enabling the development of novel platforms for studying cellular behavior in controlled microenvironments. The Lockett Lab maintains two primary research subgroups: a surfaces subgroup focusing on carbon-based electrodes for (photo)electrosynthesis and measuring wetting dynamics, and a cells subgroup developing microfluidic 3D liver models to quantify cellular metabolism. The lab is known for its collaborative spirit and interdisciplinary approach, working with researchers across chemistry, biomedical engineering, and toxicology departments.

• Burn trauma
• Infant and child health
• Medical biochemistry
• +۲ مورد دیگر

Monique Ryan serves as a Postdoctoral Research Fellow at Murdoch University's Australian National Phenome Centre, specializing in advanced metabolomic analysis for clinical applications. Her educational foundation includes: Doctor of Philosophy in Metabolic phenotyping (Murdoch University, 2019-2024) Bachelor of Biomedical Science Honours (The University of Notre Dame Australia, 2017) Bachelor of Biomedical Science (The University of Notre Dame Australia, 2014-2016) Ryans research integrates medical biochemistry with metabolomics to investigate critical health domains including burn trauma pathophysiology and infant/child metabolic disorders . Her work employs metabolic phenotyping techniques to uncover biochemical markers for improved clinical outcomes in vulnerable patient populations. Notable recognitions include: Bioanalysis Rising Star Finalist (Bioanalysis Zone, May 2024) FameLab National Semi-Finalist (FameLab Australia, July 2021) Fresh Science WA nominee (2021) As a research-focused academic, Ryan contributes to Murdoch University's national phenome research infrastructure without documented student supervision or external grant leadership in the provided materials.

Lucien Baldasمشاهده پروفایل

استاد

• Microfluidics
• Gas Microflows
• Fluidic Micro-actuators
• +۴ مورد دیگر

Lucien Baldas is a Professor in the Mechanical Engineering Department at the National Institute of Applied Sciences of Toulouse (INSA Toulouse), where he serves as Associate Dean since 2020 and previously held roles including Director for International Relations (2007-2013). He is a member of the Modeling of Mechanical Systems and Microsystems (MS2M) research group, focusing on microfluidics and gas dynamics. His research spans microfluidics , gas microflows , fluidic micro-actuators for active flow control , particle-laden flows in microchannels , and mini pneumatic systems . Key projects include coordination of the ANR/DFG Project PuCK (2023-2026), Work-Package leadership for European Projects PERSEUS and MACAO, and coordination of the MIGRATE Training Network. His work demonstrates strong integration of theoretical modeling with experimental validation across fluid dynamics applications. Analysis of his 125+ publications reveals consistent focus on microscale flow phenomena , thermal effects in gas flows , and fluidic actuator development . Recent work (2021-2025) emphasizes additive manufacturing for microsystems , high-frequency fluidic oscillators , and multi-physics integration in microfluidic devices, with significant contributions to rarefied gas dynamics and particle transport phenomena. Key Administrative Roles: Associate Dean of Mechanical Engineering Department (2020-present) Elected Board of Studies member (2022-present) Co-chair of ISTEGIM 2019 Symposium Work-Package leader for multiple EU projects Co-Leader of Microfluidics Working Group (since 1999) His teaching portfolio includes Solid Mechanics, Automatic Control, Fluid Mechanics, and Computational Fluid Dynamics at INSA Toulouse. He has supervised numerous PhD students through EU projects and coordinates international research collaborations across Europe and North America.

Stefan Stürupمشاهده پروفایل

دانشیار

• Analytical Chemistry
• Pharmaceutical Analysis
• Isotope Ratio Analysis
• +۵ مورد دیگر

Stefan Stürup is an Associate Professor in the Department of Pharmacy at the Faculty of Health Sciences, University of Copenhagen. His research focuses on advanced analytical chemistry applications for drug product characterization and identification of falsified/substandard pharmaceuticals. His primary research interests include: Application of isotope ratio analysis ($$\delta^{13}\text{C}$$, $$\delta^{2}\text{H}$$, $$\delta^{18}\text{O}$$, $$^{87}\text{Sr}/^{86}\text{Sr}$$, $$^{207}\text{Pb}/^{206}\text{Pb}$$) for drug characterization Trace element pattern analysis in pharmaceutical products ICP-MS/ICP-OES based instrumentation for trace elemental impurity determination Uptake and biotransformation of metal-based drugs Development of novel drug delivery vehicles including nanoparticles and metal complexes His recent research has focused on analyzing ibuprofen drug products, investigating isotopic patterns, trace elements, and impurities to ensure pharmaceutical quality and detect falsified products. He has also conducted significant research on metal-based drugs including platinum compounds and gold(I) complexes, examining their cellular distribution, toxicity mechanisms, and potential therapeutic applications. Dr. Stürup has supervised 7 PhD students and 34 master students, with recent projects focusing on isotope ratio analysis in pharmaceuticals and analytical method development. He teaches Pharmaceutical Analytical Chemistry and Kemiske Principper (Chemical Principles) at the bachelor's level. His professional activities include membership in COST actions focused on metal complexes and metallo-drug design, serving as a technical assessor for the Danish Accreditation and Metrology Fund (DANAK), and reviewing for 15 analytical chemistry journals since 1995. His work bridges analytical chemistry, pharmaceutical sciences, and toxicology with practical applications for drug quality control and therapeutic development.

• High-Throughput Screening
• Guanine Methyltransferases
• Antiviral Drug Discovery
• +۳ مورد دیگر

Lesley-Anne Pearson serves as Senior Biologist in the Drug Discovery Unit at the University of Dundee's School of Life Sciences. Her work bridges molecular pharmacology and public engagement through innovative art-science collaborations. Her research focuses on high-throughput screening for RNA methyltransferase inhibitors, with significant contributions to SARS-CoV-2 antiviral development. The fingerprint analysis reveals dominant expertise in Guanine Methyltransferases (66%), High-Throughput Screening (66%), and Leishmania Parasites (44%), indicating a strong focus on infectious disease targets. Recent publications (2021-2025) show consistent output in biochemical methodology and antiviral research, with notable impact on assay development. Her 2021 SLAS Discovery paper on SARS-CoV-2 inhibitors has garnered 32 Scopus citations and patent family citations. Science For All Badge 2023 (Public Engagement Award) Wellcome Trust-funded Drug Discovery Unit membership Dundee City Council collaborative projects Pearson leads extensive public engagement through the Discover Life Sciences program, Girlguiding Science Camps, and community murals. Her 'Life Space' methodology transforms complex biochemistry into accessible public health tools, demonstrating exceptional science communication impact through 4 major annual outreach initiatives.

• Reproductive Endocrinology
• Infertility
• Cell Biology
• +۳ مورد دیگر

Thomas Huang, PhD, serves as an Associate Professor at the University of Hawaii at Manoa, contributing to reproductive medicine through clinical laboratory leadership and academic instruction. His role bridges advanced laboratory science with medical education in obstetrics and gynecology contexts. Dr. Huang's academic foundation includes doctoral training in cellular mechanisms of development: PhD in Cell Biology and Mammalian Development, University of California, San Francisco School of Medicine, 1980 His expertise centers on Reproductive Endocrinology and Infertility (REI), integrating molecular biology with clinical diagnostics. This specialization drives innovations in fertility treatments and hormonal disorder management, emphasizing translational research from bench to bedside in reproductive healthcare. Professional distinctions include: High-Complexity Clinical Laboratory Director certification (American Board of Bioanalysis) As an Associate Professor, Dr. Huang oversees high-acuity laboratory operations while mentoring medical trainees. His board certification ensures adherence to stringent regulatory standards for complex reproductive diagnostics, directly impacting patient care quality and diagnostic accuracy in endocrine-related infertility cases.